1,088 research outputs found
Living in a deep desiccated Mediterranean Sea: An overview of the Italian fossil record of the Messinian salinity crisis
Crucial role of phospholamban phosphorylation and S-nitrosylation in the negative lusitropism induced by 17β-estradiol in the male rat heart.
Background/Aims: 17β-estradiol (17βE2) plays an important cardiovascular role by activating estrogen receptors (ER) α and ERβ. Previous studies demonstrated that the novel estrogen G protein-coupled receptor (GPR30/GPER) mediates estrogen action in different tissues. We have recently shown in the rat heart that 17βE2 elicits negative inotropism through ERα, ERβ and GPR30, by triggering activation of ERK1/2, phosphatidylinositol 3-kinase (PI3K), protein kinase A (PKA) and endothelial Nitric Oxide synthase (eNOS) signaling. Methods: In the present study, using the isolated and Langendorff-perfused rat heart as a model system we analyzed: i) whether and to which extent 17βE2 modifies mammalian ventricular myocardial relaxation (lusitropism); ii) the type of ERs and the signaling pathways involved in this effect. Results: We found that 17βE2 negatively modulated the ventricular lusitropic performance. This effect, which partially involved the vascular endothelium, recruited ERβ and occurred via PI3K, eNOS-NO-cGMP-protein kinase G (PKG) transduction cascade. Of note, 17βE2-mediated negative lusitropism associated with a modification of phospholamban (PLN) phosphorylation and S-nitrosylation (SNO) both in isolated Langendorff rat heart and in isolated cardiomyocytes. Conclusion: Taken together, our results allow including 17βE2 to the family of substances that control ventricular relaxation. This is of relevance in relation not only to the normal endocrine control of cardiac function, but also to physio-pathologic conditions characterized by an altered ventricular diastolic performance
Can deep sub-wavelength cavities induce Amperean superconductivity in a 2D material?
Amperean superconductivity is an exotic phenomenon stemming from attractive
effective electron-electron interactions (EEEIs) mediated by a transverse gauge
field. Originally introduced in the context of quantum spin liquids and high-Tc
superconductors, Amperean superconductivity has been recently proposed to occur
at temperatures on the order of 1-20 K in two-dimensional, parabolic-band,
electron gases embedded inside deep sub-wavelength optical cavities. In this
work, we first generalize the microscopic theory of cavity-induced Amperean
superconductivity to the case of graphene and then argue that this
superconducting state cannot be achieved in the deep sub-wavelength regime. In
the latter regime, indeed, a cavity induces only EEEIs between density
fluctuations rather than the current-current interactions which are responsible
for Amperean pairing.Comment: 25 pages. Replaced with a greatly modified version, with the addition
of an entirely new Section. This new Section presents a Green's function
approach to EEEIs that highlights the profound difference between planar
optical cavities and sub-wavelength cavitie
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid
BACKGROUND There is a recognized association between inflammatory bowel disease (IBD) and hepatobiliary autoimmune disease, particularly primary sclerosing cholangitis (PSC). There have been fewer reported cases of IBD and primary biliary cholangitis (PBC), which is treated with ursodeoxycholic acid (UDCA). This report presents the case of a 60-year-old woman with PBC who was diagnosed with Crohn's ileitis after suspension of UDCA treatment. CASE REPORT A 66-year-old female patient with PBC was admitted to our department for irrepressible chronic diarrhea and recurrent abdominal pain. PBC was diagnosed on the basis of serological data: chronic (>6 months) increase in alkaline phosphatase (ALP) associated with positivity for specific anti-nuclear antibodies (sp100 and gp210), without requiring a liver biopsy and a magnetic resonance cholangiopancreatography to rule out PSC. Given the intolerance and non-responsiveness according to the Toronto criteria (ALP <1.67 times the normal limit after 2 years) to UDCA at 15 mg/kg/day, an oral monotherapy treatment using obeticholic acid at 5 mg/day was prescribed. The patient complained of abdominal pain and upper gastrointestinal symptoms. The endoscopic/histologic and radiologic examinations supported the diagnosis of Crohn's ileitis. Given the potential benefits to PBC patients of what is described as off-label therapy, budesonide at a dosage of 9 mg/day p.o. was also administered. One month after discharge, an improvement was observed both in the cholestasis indices and in gastrointestinal symptoms. CONCLUSIONS This report presents a case of PBC in which the patient was diagnosed with Crohn's ileitis after cessation of treatment with UDCA, and highlights the importance of recognizing the association between autoimmune hepatobiliary disease and IBD
Cancer incidence in pet dogs: findings of the Animal Tumor Registry of Genoa, Italy.
Background: The occurrence of spontaneous tumors in pet animals has been estimated in a few European and North American veterinary cancer registries with dissimilar methodologies and variable reference populations. Objectives: The Animal Tumor Registry (ATR) of Genoa, Italy, was established in 1985 with the aim of estimating the occurrence of spontaneous tumors in dogs. Methods: Six thousand seven hundred and forty-three tumor biopsy specimens were received from local veterinarians in the Municipality of Genoa between 1985 and 2002. Three thousand and three hundred and three (48.9%) biopsy specimen samples were diagnosed as cancer and were coded according to the International Statistical Classification of Diseases (ICD-9). Results: Mammary cancer was the most frequently diagnosed cancer in female dogs, accounting for 70% of all cancer cases. Incidence of all cancers was 99.3 per 100,000 dog-years (95% CI: 93.6–105.1) in male dogs and 272.1 (95% CI: 260.7–283.6) in female dogs. The highest incidence rates were detected for mammary cancer (IR = 191.8, 95% CI: 182.2–201.4) and for non-Hodgkin's lymphoma (IR = 22.9, 95% CI: 19.7–26.5) in bitches and for non-Hodgkin's lymphoma (IR = 19.9, 95% CI: 17.4–22.7) and skin cancer (IR = 19.1, 95% CI: 16.6–21.8) in male dogs. All cancer IR increased with age ranging between 23.7 (95% CI: 18.4–30.1) and 763.2 (95% CI: 700.4–830.1) in bitches and between 16.5 (95% CI: 12.8–21.1) and 237.6 (95% CI: 209.1–269.0) in male dogs aged ≤3 years and >9–11 years. Conclusion: This study summarizes the work done by the ATR of Genoa, Italy, between 1985 and 2002. All cancer incidence was 3 times higher in female than in male dogs, a difference explained by the high rate of mammary cancer observed in bitches. Because a biopsy specimen was required to make a cancer diagnosis, cancer rates for internal organs cancers, such as respiratory and digestive tract cancers may have been underestimated in the study population
Paleoenvironmental change in a precession-paced succession across the onset of the Messinian salinity crisis: Insight from element geochemistry and molecular fossils
Esterase Cleavable 2D Assemblies of Magnetic Iron Oxide Nanocubes: Exploiting Enzymatic Polymer Disassembling to Improve Magnetic Hyperthermia Heat Losses
Here, we report a nanoplatform based on iron oxide nanocubes (IONCs) coated with a bioresorbable polymer that, upon exposure to lytic enzymes can be disassembled increasing the heat performances in comparison with the initial clusters. We have developed bi-dimensional (2D) clusters by exploiting benchmark iron oxide nanocubes as heat mediators for magnetic hyperthermia and a polyhydroxyalkanoate (PHA) copolymer, a biodegradable polymer produced by bacteria that can be digested by intracellular esterase enzymes. The comparison of magnetic heat performance of the 2D assemblies with 3D centro-symmetrical assemblies or single iron oxide nanocubes emphasize the benefit of the 2D assembly. On one hand, the heat losses of 2D assemblies dispersed in water are better than the 3D assemblies, but worse than for single nanocubes. On the other hand, when the bi-dimensional magnetic beads (2D-MNBs) are incubated with the esterase enzyme at a physiological temperature, their magnetic heat performances began to progressively increase. After 2 hours of incubation, specific absorption rate values of the 2D assembly double the ones of individually coated nanocubes. Such an increase can be mainly correlated to the splitting of the 2D-MNBs into smaller size clusters with a chain- like configuration containing few nanocubes. Moreover, 2D-MNBs exhibited non-variable-heat performances even after intentionally inducing their aggregation. Magnetophoresis measurements indicate a comparable response of 3D and 2D clusters to external magnets (0.3T) that is by far faster than that of single nanocubes. This feature is crucial for a physical accumulation of magnetic materials in the presence of magnetic field gradients. This system is the first example of a nanoplatform that, upon exposure to lytic enzymes, such as those present in a tumor environment, can be disassembled from the initial 2D-MNB organization to chain-like assemblies with clear improvement of the heat magnetic losses resulting in better heat dissipation performances. The potential application of 2D nano-assemblies based on the cleavable PHAs for preserving their magnetic losses inside cells will benefit hyperthermia therapies mediated by magnetic nanoparticles under alternating magnetic fields
Human, donkey and cow milk differently affects energy efficiency and inflammatory state by modulating mitochondrial function and gut microbiota
n/
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma
Simple Summary: Despite crucial scientific advances, Glioblastoma (GB) remains a fatal disease with
limited therapeutic options and a lack of suitable biomarkers. The unveiled competence of the brain
immune system together with the breakthrough advent of immunotherapy has shifted the present
translational research on GB towards an immune-focused perspective. Several clinical trials targeting
the immunosuppressive GB background are ongoing. So far, results are inconclusive, underpinning
our partial understanding of the complex cancer-immune interplay in brain tumors. High throughput
Magnetic Resonance (MR) imaging has shown the potential to decipher GB heterogeneity, including
pathologic and genomic clues. However, whether distinct GB immune contextures can be deciphered
at an imaging scale is still elusive, leaving unattained the non-invasive achievement of prognostic
and predictive biomarkers. Along these lines, we integrated genetic, immunopathologic and imaging
features in a series of GB patients. Our results suggest that multiparametric approaches might
offer new efficient risk stratification models, opening the possibility to intercept the critical events
implicated in the dismal prognosis of GB.
Abstract: Background: The aim of the present study was to dissect the clinical outcome of GB patients
through the integration of molecular, immunophenotypic and MR imaging features. Methods: We
enrolled 57 histologically proven and molecularly tested GB patients (5.3% IDH-1 mutant). Two-
Dimensional Free ROI on the Biggest Enhancing Tumoral Diameter (TDFRBETD) acquired by MRI
sequences were used to perform a manual evaluation of multiple quantitative variables, among which
we selected: SD Fluid Attenuated Inversion Recovery (FLAIR), SD and mean Apparent Diffusion
Coefficient (ADC). Characterization of the Tumor Immune Microenvironment (TIME) involved the
immunohistochemical analysis of PD-L1, and number and distribution of CD3+, CD4+, CD8+ Tumor
Infiltrating Lymphocytes (TILs) and CD163+ Tumor Associated Macrophages (TAMs), focusing on
immune-vascular localization. Genetic, MR imaging and TIME descriptors were correlated with
overall survival (OS). Results: MGMT methylation was associated with a significantly prolonged OS
(median OS = 20 months), while no impact of p53 and EGFR status was apparent. GB cases with high
mean ADC at MRI, indicative of low cellularity and soft consistency, exhibited increased OS (median
OS = 24 months). PD-L1 and the overall number of TILs and CD163+TAMs had a marginal impact
on patient outcome. Conversely, the density of vascular-associated (V) CD4+ lymphocytes emerged
as the most significant prognostic factor (median OS = 23 months in V-CD4high vs. 13 months in
V-CD4low, p = 0.015). High V-CD4+TILs also characterized TIME of MGMTmeth GB, while p53mut
appeared to condition a desert immune background. When individual genetic (MGMTunmeth), MR
imaging (mean ADClow) and TIME (V-CD4+TILslow) negative predictors were combined, median OS was 21 months (95% CI, 0–47.37) in patients displaying 0–1 risk factor and 13 months (95% CI
7.22–19.22) in the presence of 2–3 risk factors (p = 0.010, HR = 3.39, 95% CI 1.26–9.09). Conclusion:
Interlacing MRI–immune–genetic features may provide highly significant risk-stratification models
in GB patients
- …